This is in contrast to a limitless-arity multiple-testing procedure approach which identified that a cumulative combination of proton pump inhibitors, high plasma BNP levels, diuretics use, advanced age, and lack of anti-dyslipidemia drugs increases the overall risk of HF [44]. This evidence concerns the gene NPPB and metabolic syndrome.